Indivior Pharmaceuticals (INDV) Capital Expenditures (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Capital Expenditures of $20.0 million for Q1 2026, up 300.0% year-over-year from $5.0 million in Q1 2025, and down 16.67% quarter-over-quarter from $24.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Capital Expenditures (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Capital Expenditures history runs 3 years deep, the most recent figure standing at $20.0 million for Q1 2026.
- In Q1 2026, Capital Expenditures rose 300.0% year-over-year to $20.0 million; the TTM figure through Mar 2026 stood at $81.0 million (up 153.12% YoY), while the FY2025 annual figure was $66.0 million, up 127.59% from the prior year.
- Capital Expenditures for Q1 2026 stood at $20.0 million, down from $24.0 million in the prior quarter.
- The five-year high for Capital Expenditures was $24.0 million in Q4 2025, with the low at $2.0 million in Q1 2024.
- The 3-year median for Capital Expenditures is $16.0 million (2024), against an average of $12.8 million.
- Peak annual rise in Capital Expenditures reached 325.0% in 2025, while the deepest fall reached 50.0% in 2025.
- Indivior Pharmaceuticals' Capital Expenditures stood at $16.0 million in 2024, then jumped by 50.0% to $24.0 million in 2025, then fell by 16.67% to $20.0 million in 2026.
- Business Quant data shows INDV's Capital Expenditures at $20.0 million in Q1 2026, $24.0 million in Q4 2025, and $20.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn | 7.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.00 Mn |
| Jun 30, 2026 | 7.00 Mn |
| Mar 31, 2026 | 20.00 Mn |
| Mar 31, 2026 | 20.00 Mn |
| Dec 31, 2025 | 24.00 Mn |
| Dec 31, 2025 | 24.00 Mn |
| Sep 30, 2025 | 20.00 Mn |
| Sep 30, 2025 | 20.00 Mn |
| Jun 30, 2025 | 17.00 Mn |
| Jun 30, 2025 | 17.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 16.00 Mn |
| Dec 31, 2024 | 16.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |